News and Comments

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Intermune (ITMN) Ridaforolimus Zerenex NANTKWEST (NK) Exelixis (EXEL) Jazz Pharmaceuticals (JAZZ) KERYX (KERX) ZALTRAP™ Endometrial Cancer Rapamune Benlysta (belimumab) Xoma (XOMA) Human Genome Sciences (HGSI) Elan (ELN) Revlimid (lenolidamide) Array Pharmaceuticals (ARRY) AstraZeneca (AZN) SUNESIS PHARMACEUTICALS (SNSS) Inovio (INO) Telaprevir Biogen Idec (BIIB) Trastuzumab-DM1 PORTOLA (PTLA) Vitae Pharmaceuticals (VTAE) Mirati Therapeutics (MRTX) SERES THERAPEUTICS (MCRB) CRISPR Therapeutics (CRSP) GUARDIAN HEALTH IDERA (IDRA) Amgen (AMGN) Alder Biopharmaceuticals (ALDR) Merck (MRK) Adaptimmune (ADAP) Auspex (ASPX) Sangamo (SGMO) ISIS (ISIS) Valeant Pharmaceuticals International (VRX) Velcade (bortezomib) CEMPRA (CEMP) Global Cell Therapeutics (GBT) Anacor (ANAC) Galena (GALE) HALOZYME (HALO) Sanofi-Aventis (SAN) TOKAI (TKAOI) JUNO (JUNO) Aimmune Therapeutics (AIMT) Idenix (IDIX) KITE (KITE) Alnylam (ALNY) AGOS (ARGS) Theravance Bio Pharma (TBPH) NEKTAR (NKTR)) Bellicum (BLCM) PTC Therapeutics (PTCT) BIOMARIN (BMRN) Illumina (ILMN) Dynavax (DVAX) ARCA (ABIO) Cytokinetics (CYTK) Micromet (MITI) Ocular Therapeutix (OCUL) MODERNA Sanofi (SNY) SYNTA (SNTA) Biocryst (BCRX) INNOVIVA (INVA) galapagos (GLPG) CompuGen (CGEN) NOVOCURE (NVCR) AERIE PHARMACEUTICALS Theravance (THRX) Dendreon (DNDN) RenenxBio (RGNX) Herceptin Ariad (ARIA) Agenus (AGEN) Agenus (AGEN ARGOS (ARGS) Anadys (ANDS) Incyte (INCY) Onyx (ONXX) Genentech Roche (RHHBY) REGULUS (RGLS) Multiple Myeloma Advaxis (ADXS) GlaxoSmithKline (GSK) ADVENTRIX (ANX) Editas (EDIT) Gilead (GILD) Vertex (VRTX) Sarepta (SRPT) ImmunoGen (IMGN) ABBVIE (ABBV) Roche (ROCHE) OSI (OSIP) Spike Therapeutics (ONCE) Pluristem (PSTI) Regeneron (REGN) Abbott Laboratories (ABT) C4 Therapeutics Ziofpharm (ZIOP) Intercept (ICPT) Sequenom (SQNM) Bristol-Myers Squibb (BMY) Ionis (IONS) Seattle Genetics (SGEN) ACADIA (ACAD) Sanofi (SNA) Tysabri Prosensa (RNA) Human Longevity (HLI) Intrexon (XON) Prolor Biotech (PBTH) VANDA (VNDA)